* Galileo was successfully acquired by San Diego-based Antharis Therapeutics Inc., in August 2023.
The company, now a wholly-owned subsidiary of Antharis Therapeutics, is headquartered in San Diego, USA. Its state-of-the-art R&D laboratory and certified production facility is located in the city of Rio de Janeiro Brazil.
Galileo is a science-driven company focused on the development and production of in-vitro diagnostics products and cutting-edge therapeutic monoclonal antibodies for devastating human diseases, in particular cancer.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Avenida Das Américas, 12.900, Loja Ss 115,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- galileobio.com
- Keywords
- biotech, IVD, diagnostics, immunology, immunochemistry, food safety, human health, animal health, ELISA, antibody, monoclonal antibody, polyclonal antibody.
- HQ
- Rio de Janeiro, Rio de Janeiro
Galileo Biotech Questions
Galileo Biotech's website is galileobio.com
Galileo Biotech's LinkedIn profile is https://www.linkedin.com/company/galileo-biotechnology
Galileo Biotech has
11 employees.
View email and phone details for 11
employees at Galileo Biotech.
Galileo Biotech's industry is
Biotechnology Research
Galileo Biotech's top competitors are
Apc Biotecnologia,
Bionovis,
Prointer Bio&tech - Sebrae Rj,
Biozeus Biopharmaceutical S.a.,
Bio Bureau Biotechnology,
Antharis Therapeutics, Inc.,
Aeterna Therapeutics,
Cassyni Biopharma,
Biolinker,
Receptabio.
Galileo Biotech's categories are Biotechnology Research
Galileo Biotech's founding year is 2015
